"Stay up-to-date on the latest medical news and breakthroughs with our comprehensive and reliable healthcare blog. Get expert insights and analysis on a wide range of medical topics."
Psychiatric disorders such as major depressive disorder (MDD), bipolar disorder, and schizophrenia often require advanced treatment options when conventional therapies fail. Electroconvulsive Therapy (ECT) has been a longstanding intervention for severe cases, but its cognitive side effects have led researchers to explore safer alternatives. Magnetic Seizure Therapy (MST) emerges as a promising, less invasive option that combines the efficacy of ECT with reduced adverse effects.
Recently, India’s National Institute of Mental Health and Neurosciences (NIMHANS) in Bengaluru inaugurated MST, marking a significant milestone in psychiatric care in the country. This blog explores MST in detail, its mechanism, benefits, and how NIMHANS is pioneering its use in India.
What is Magnetic Seizure Therapy (MST)?
Magnetic Seizure Therapy is a neurostimulation technique that induces controlled seizures in the brain using high-frequency magnetic pulses. Unlike ECT, which uses electric currents, MST employs repetitive transcranial magnetic stimulation (rTMS) at higher intensities to trigger therapeutic seizures.
How Does MST Work?
1. Magnetic Stimulation:
– An electromagnetic coil is placed on the patient’s scalp.
– Rapid magnetic pulses generate electric currents in targeted brain regions, typically the prefrontal cortex.
– These pulses induce a brief seizure under controlled conditions.
– It enhances neurotransmitter release (serotonin, dopamine, GABA) and stimulates neurogenesis.
– The seizure activity is more focal than in ECT, reducing cognitive side effects.
3. Procedure:
– Conducted under anesthesia and muscle relaxants (similar to ECT).
– Sessions last about 15-30 minutes, with patients requiring multiple treatments (typically 6-12 sessions).
MST vs. ECT: Key Differences
Feature
Magnetic Seizure Therapy (MST)
Electroconvulsive Therapy (ECT)
Stimulation Type
Magnetic impulses
Electrical currents
Precision
More focal, target specific areas
Less precise, broader stimulation
Side effects
Fewer memory and cognitive issues
Higher risk of memory loss
Anesthesia
Required
Required
Efficacy
Comparable to ECT in early studies
Well-established efficacy
Advantages of MST Over ECT
1. Reduced Cognitive Side Effects
– ECT is associated with memory loss and confusion.
– MST’s focal stimulation minimizes these risks.
2. Better Tolerability
– Patients report fewer headaches and muscle pains post-treatment.
3. Non-Invasive Nature
– Unlike ECT, MST does not require electrodes to be attached to the scalp.
4. Potential for Outpatient Use
– Due to its safety profile, MST may eventually be administered in outpatient settings.
Disadvantages and Limitations
1. Limited Long-Term Data
– MST is relatively new, and long-term effects are still under study.
2. Availability and Cost
– Currently, only a few centers worldwide offer MST.
– The treatment may be expensive compared to ECT.
3. Not Universally Effective
– Some patients may not respond to MST, requiring alternative treatments.
NIMHANS Introduces MST in India
The National Institute of Mental Health and Neurosciences (NIMHANS), a premier mental health institution in India, has recently inaugurated Magnetic Seizure Therapy (MST) as part of its advanced psychiatric treatments. This marks a significant leap in India’s mental healthcare, offering a modern alternative to ECT.
Why is NIMHANS Adopting MST?
1. Cutting-Edge Treatment for Resistant Depression
– Many patients with treatment-resistant depression (TRD) do not respond to medications or psychotherapy.
– MST provides a new hope for such cases.
2. Commitment to Innovation
– NIMHANS has been a pioneer in neurosciences, introducing deep brain stimulation (DBS), rTMS, and now MST.
3. Reducing Stigma Around Shock Therapies
– ECT has been stigmatized due to its side effects.
– MST’s improved safety profile may encourage more patients to seek help.
How Will MST Be Implemented at NIMHANS?
Patient Selection: MST will be offered to patients with severe depression, bipolar disorder, or schizophrenia who have not responded to other treatments.
Research and Trials: NIMHANS will likely conduct clinical studies to assess MST’s efficacy in the Indian population.
Training for Psychiatrists: Specialized training programs will ensure proper administration of MST.
Global Status of MST
While MST is still in the experimental and early-adoption phase, several countries are exploring its potential:
Canada: The Centre for Addiction and Mental Health (CAMH) in Toronto has implemented MST for treatment-resistant cases.
India’s adoption of MST through NIMHANS places it among the few nations advancing this therapy.
Future of MST in Psychiatry
1. Expansion to Other Disorders
– Researchers are investigating MST for Parkinson’s disease, OCD, and PTSD.
2. Technological Improvements
– Advancements in coil design may enhance precision.
3. Home-Based MST Devices (Speculative)
– If safety is further proven, portable MST devices could emerge.
Conclusion
Magnetic Seizure Therapy represents a paradigm shift in psychiatric treatment, offering a safer alternative to ECT with comparable efficacy. NIMHANS’ introduction of MST in India is a groundbreaking development, providing new hope for patients with severe, treatment-resistant mental illnesses.
As research progresses, MST could become a mainstream therapy, reducing the stigma associated with brain stimulation treatments. For now, it stands as a testament to how innovation in neuroscience can transform mental healthcare.
FAQs About MST
1. Is MST painful?
– No, patients are under anesthesia and do not feel pain during the procedure.
2. How many MST sessions are needed?
– Typically 6-12 sessions, depending on the patient’s response.
3. Is MST available in all Indian hospitals?
– Currently, only NIMHANS offers MST in India, but other hospitals may adopt it soon.
4. Can MST replace ECT completely?
– Not yet, as ECT remains more widely studied, but MST may become a preferred option in the future.
5. Are there any risks with MST?
– Side effects are milder than ECT but may include mild headaches or temporary confusion.
With MST now available at NIMHANS, India is stepping into the future of psychiatric care, offering patients a safer, more effective treatment option.
You May Also Like
Never Miss visiting NIMHANS Brain Museum: Click Here
To Know Speech and Language Pathology Department of NIMHANS: Click Here
